The value of positron-emission tomography (PET) in the follow-up of patients with rectal carcinoma;Die wertigkeit der positronenemissionstomographie (PET) in der nachsorge des rektumkarzinoms

Coloproctology

Volumn 24, Issue 4, 2002, Pages 197-202

  Timm, Stephan ^a   Sailer, Marco A ^a   Baum, Richard Paul ^a   Debus, Sebastian ^a   Thiede, Arnulf ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

PET; Rectal carcinoma; Tumor recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; PELVIS TUMOR; POSITRON EMISSION TOMOGRAPHY; RECTUM ANASTOMOSIS; RECTUM CARCINOMA; REOPERATION; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

EID: 0036693527     PISSN: 01742442     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00053-002-5075-z     Document Type: Article

References (16)

1. Positron emission tomography and colorectal cancer
2. PET scanning in malignancy: Infant, adolescent or mature citizen?
3. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
4. Die wertigkeit der positronen-emissionstomography in der diagnostik von rectum-rezidivkarzinomen
5. Fluorine-18 fluorodeoxy-glucose positron emission tomography in thyroid cancer: Results of a multicenter study
6. Transport of sugars in tumour cell membranes
7. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer
8. Cancer statistics 1997
9. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with suspected pancreatic cancer
10. Einfluss der positronenemissionstomographie auf die chirurgische therapieplanung beim colorectalen rezidivtumor
11. PET-untersuchungen des rückfälligen rectumkarzinoms
12. Clinical assessment of positron emission tmography for the diagnosis of local recurrence in colorectal cancer
13. On the metabolism of tumours in the body
14. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
15. FDG PET immunoscintigraphy with 99m TC-labeled antibody fragments for detection of the recurrence of colorectal cancer
16. Increased accumulation of 2-deoxy-2-18F fluoro-D-glucose in liver metastases from colon carcinoma